BJMO - volume 10, issue 5, august 2016
V. Surmont MD, PhD
During ASCO 2016, 190 abstracts were presented in the lung cancer track: 18 oral presentations, 22 discussion sessions and 172 posters. This report will highlight 7 selected phase III trials and 3 small but promising phase I/II trials.
This year’s ASCO focused on the promising and exciting domain of immunotherapy with checkpoint inhibitors. Of special interest were the data in first line treatment of NSCLC, the combination of PD-L1 and CTLA-4 antibodies, and the phase I/II results in mesothelioma, small cell lung cancer and thymic carcinoma.
Other highlights of ASCO 2016 in the field of thoracic oncology included updated results of new targeted therapies for patients with defined molecular targets and for patients with acquired resistance after firstgeneration EGFR or ALK-inhibitors.
(BELG J MED ONCOL 2016;10(5):179–185)
Read moreBJMO - volume 10, issue 5, august 2016
P. Specenier MD, PhD
(BELG J MED ONCOL 2016;10(5):186–189)
Read moreBJMO - volume 10, issue 5, august 2016
S. Altintas MD, PhD
(BELG J MED ONCOL 2016;10:190–196)
Read moreBJMO - volume 10, issue 4, july 2016
H. Van Poppel MD, PhD
The 13th meeting of the EAU Section of Oncological Urology took place in Warsaw in January 2016. The most important newcomers were the checkpoint inhibitors in metastatic renal cell carcinoma and in bladder cancer. In prostate cancer, early administration of docetaxel in newly diagnosed metastatic prostate cancer was the major practice changing news, next to whole exome and transcriptome sequencing that will become important
(BELG J MED ONCOL 2016;10(4):143–146)
Read moreBJMO - volume 10, issue 3, may 2016
L. Decoster MD, PhD
Report from the 2015 Annual Meeting of the International Society of Geriatric Oncology (SIOG).
The 2015 Annual Conference of the International Society of Geriatric Oncology took place in Prague, Czech Republic from November 12–14th. More than 400 delegates with a special interest in the care for older patients with cancer attended this conference, including medical oncologists, geriatricians, surgeons, nurses and other professional health care workers. The meeting provided an overview of current advances in geriatric oncology domains.
(BELG J MED ONCOL 2016;10(3):108–9)
Read moreBJMO - volume 10, issue 2, april 2016
S. Ward MD, E. Wouter MD, D. De Ridder MD, PhD
21–22 September 2015, Leuven, Belgium
(BELG J MED ONCOL 2016;10(2):76-80)
Read moreBJMO - volume 10, issue 1, february 2016
Tom Feys MBA, MSc
From the 8th till the 12th of December, San Antonio, TX was again transformed into the world’s capital in the fight against breast cancer. The 2015 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) was a joint presentation of the Cancer Therapy & Research Centre at the University of Texas Health Science Centre in San Antonio, the American Association for Cancer Research, and the Baylor College of Medicine. This years’ meeting drew more than 6,000 participants from all over the globe and again proved to be the number one breast cancer meeting in the world. This report will highlight seven key studies presented during the meeting.
(BELG J MED ONCOL 2016;10(1):41–43)
Read more
Top
